Your browser doesn't support javascript.
loading
Impact of adiposity on clinical outcomes in people living with a Fontan circulation.
Cao, Jacob Y; Tran, Derek; Briody, Julie; Attard, Chantal; Hassan, Ebrahim Bani; Simm, Peter; Burchill, Luke; Twigg, Stephen M; Fiatarone-Singh, Maria A; Ayer, Julian; Celermajer, David S; d'Udekem, Yves; Cordina, Rachael.
Afiliación
  • Cao JY; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Tran D; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Briody J; Department of Nuclear Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Attard C; Haematology Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
  • Hassan EB; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC, Australia; Department of Medicine-Western Health, The University of Melbourne, St. Albans, VIC, Australia.
  • Simm P; Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, VIC, Australia; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Burchill L; Department of Cardiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Twigg SM; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Fiatarone-Singh MA; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Ayer J; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Celermajer DS; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • d'Udekem Y; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia; Heart Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Royal Children's Hospital, Melbourne, VIC, Australia.
  • Cordina R; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Heart Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia. Electronic address: rachael
Int J Cardiol ; 329: 82-88, 2021 04 15.
Article en En | MEDLINE | ID: mdl-33387555
ABSTRACT

BACKGROUND:

To assess the association between body composition and the risk of adverse outcomes in Fontan patients.

METHODS:

Participants from the Australian and New Zealand Fontan Registry with dual-energy X-ray absorptiometry scans were included. Appendicular lean mass (ALM), appendicular lean mass index (ALM divided by height squared; ALMI) and total body fat mass percentage (%BF) were calculated. ALMI and %BF z-scores were derived using age- and sex-matched reference ranges. The primary outcome was Fontan failure (death, transplantation, New York Heart Association functional class III/IV, protein-losing enteropathy, and plastic bronchitis) or moderate-or-severe ventricular dysfunction.

RESULTS:

144 patients were included. Mean %BF was 29% (SD 10) with 50% having increased adiposity. Mean ALMI z-score was -1.4 (SD 1.1); one third of patients had skeletal muscle deficiency (ALMI z-score < -1 and -2) and another third had Fontan-associated myopaenia (ALMI z-score < -2). Age and %BF were associated with the risk of the endpoint in univariable regression (age HR 1.09 per year, 95% CI 1.02-1.17, p = 0.01; %BF HR 1.08, 95% CI 1.01-1.17, p = 0.03). On multivariable regression, every 1% increase in %BF was associated with a 10% increased risk of reaching the clinical endpoint (HR 1.10, 95% CI 1.01-1.19; p = 0.03). ALM was not associated with the endpoint (HR 1.02 per kg, 95% CI 0.88-1.20, p = 0.77).

CONCLUSIONS:

Increased adiposity is associated with higher risk for adverse outcomes. Prospective studies to assess lifestyle interventions to optimise body composition should be prioritised.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Procedimiento de Fontan / Adiposidad Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Procedimiento de Fontan / Adiposidad Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Australia